Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/20/26 16:33 | 1/15/26 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | 4 | M.dm | 3,609 | 10.96 | 0 | 329 | 63 | D | |||||||||||||||
1/20/26 16:33 | 1/15/26 | DVAX | Health | Drug | Pharmaceutical Preparations | Novack David F | CA | O | P,COO | 4 | S.dm | -3,609 | 10.96 | 0 | -329 | 63 | D | |||||||||||||||
12/29/25 16:15 | 12/23/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Macdonald Kelly | CA | O | SVP,CFO | 1 | M.d | 0 | 0.00 | 0 | 30 | 97 | 60 | D | ||||||||||||||
12/29/25 16:12 | 12/23/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Metzinger Joseph Anthony | CA | O | VP,Chief | 1 | M.d | 0 | 0.00 | 0 | 13 | 7 | D | |||||||||||||||
12/29/25 16:08 | 12/23/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Slebir John L | CA | O | SVP GC | 1 | M.d | 0 | 0.00 | 0 | 31 | 79 | 70 | D | ||||||||||||||
12/29/25 16:05 | 12/23/25 | DVAX | Health | Drug | Pharmaceutical Preparations | Spencer Ryan | CA | DO | CEO,Dir | 1 | M.d | 0 | 0.00 | 0 | 100 | 36 | 380 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |